Chlorambucil targets BRCA 1/2‐deficient tumours and counteracts PARP inhibitor resistance

Summary

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Eliana MC Tacconi, Sophie Badie, Giuliana De Gregoriis, Timo Reisländer, Xianning Lai, Manuela Porru, Cecilia Folio, John Moore, Arnaud Kopp, Júlia Baguña Torres, Deborah Sneddon, Marcus Green, Simon Dedic, Jonathan W Lee, Ankita Sati Batra, Oscar M Rueda, Alejandra Bruna, Carlo Leonetti, Carlos Caldas, Bart Cornelissen, Laurent Brino, Anderson Ryan, Annamaria Biroccio, Madalena Tarsounas

Journal title: EMBO Molecular Medicine

Journal number: 11/7

Journal publisher: John Wiley & Sons Ltd.

Published year: 2019

DOI identifier: 10.15252/emmm.201809982

ISSN: 1757-4676